Drostanolone propionate

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Drostanolone propionate
Accession Number
DB14655
Description
Not Available
Type
Small Molecule
Groups
Approved, Illicit
Structure
Thumb
Weight
Average: 360.538
Monoisotopic: 360.266445019
Chemical Formula
C23H36O3
Synonyms
  • 17β-Hydroxy-2α-methyl-5α-androstan-3-one propionate
  • 2M-DHTP
  • 2MDTP
  • 2α-Methyl-4,5-dihydrotestosterone propionate
  • Blackburn Compound
  • Dromostanolone propionate
  • Drostanolone propionate
  • Emdisterone
  • Testosterone, 4,5α-dihydro-2α-methyl-, propionate
External IDs
  • Re 346
  • RS 1567

Pharmacology

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Indication

For use in females, for palliation of androgenresponsive recurrent mammary cancer in women who are more than one year but less than five years postmenopausal.

Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics

Dromostanolone is a synthetic androgen, or male hormone, similar to testosterone. Dromostanolone works by attaching itself to androgen receptors; this causes it to interact with the parts of the cell involved in the making of proteins. It may cause an increase in the synthesis of some proteins or a decrease in the synthesis of others. These proteins have a variety of effects, including blocking the growth of some types of breast cancer cells, stimulating cells that cause male sexual characteristics, and stimulating the production of red blood cells.

Mechanism of action

Dromostanolone is a synthetic androgenic anabolic steroid and is approximately 5 times as potent as natural methyltestosterone. Like testosterone and other androgenic hormones, dromostanolone binds to the androgen receptor. This causes downstream genetic transcriptional changes. This ultimately causes retention of nitrogen, potassium, and phosphorus; increases protein anabolism; and decreases amino acid catabolism. The antitumour activity of dromostanolone appears related to reduction or competitive inhibition of prolactin receptors or estrogen receptors or production.

Absorption

Well absorbed following parenteral administration.

Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity

Side effects include virilization (masculine traits in women), acne, fluid retention, and hypercalcemia.

Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AbciximabDrostanolone propionate may increase the anticoagulant activities of Abciximab.
AcenocoumarolDrostanolone propionate may increase the anticoagulant activities of Acenocoumarol.
AlteplaseDrostanolone propionate may increase the anticoagulant activities of Alteplase.
AncrodDrostanolone propionate may increase the anticoagulant activities of Ancrod.
AnistreplaseDrostanolone propionate may increase the anticoagulant activities of Anistreplase.
Antithrombin AlfaDrostanolone propionate may increase the anticoagulant activities of Antithrombin Alfa.
Antithrombin III humanDrostanolone propionate may increase the anticoagulant activities of Antithrombin III human.
ApixabanDrostanolone propionate may increase the anticoagulant activities of Apixaban.
ArdeparinDrostanolone propionate may increase the anticoagulant activities of Ardeparin.
ArgatrobanDrostanolone propionate may increase the anticoagulant activities of Argatroban.
Interactions
Improve patient outcomes
Build effective decision support tools with the industry’s most comprehensive drug-drug interaction checker.
Learn more
Food Interactions
Not Available

Products

Products
Comprehensive & structured drug product info
From application numbers to product codes, connect different identifiers through our commercial datasets.
Learn more
Easily connect various identifiers back to our datasets
Learn more
International/Other Brands
Drolban (Lilly) / Masteril (Syntex) / Masteron (Recordati)

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as steroid esters. These are compounds containing a steroid moiety which bears a carboxylic acid ester group.
Kingdom
Organic compounds
Super Class
Lipids and lipid-like molecules
Class
Steroids and steroid derivatives
Sub Class
Steroid esters
Direct Parent
Steroid esters
Alternative Parents
Androgens and derivatives / 3-oxo-5-alpha-steroids / Cyclic ketones / Carboxylic acid esters / Monocarboxylic acids and derivatives / Organic oxides / Hydrocarbon derivatives
Substituents
3-oxo-5-alpha-steroid / 3-oxosteroid / Aliphatic homopolycyclic compound / Androgen-skeleton / Androstane-skeleton / Carbonyl group / Carboxylic acid derivative / Carboxylic acid ester / Cyclic ketone / Hydrocarbon derivative
Molecular Framework
Aliphatic homopolycyclic compounds
External Descriptors
steroid ester (CHEBI:31523)

Chemical Identifiers

UNII
X20UZ57G4O
CAS number
521-12-0
InChI Key
NOTIQUSPUUHHEH-UXOVVSIBSA-N
InChI
InChI=1S/C23H36O3/c1-5-21(25)26-20-9-8-17-16-7-6-15-12-19(24)14(2)13-23(15,4)18(16)10-11-22(17,20)3/h14-18,20H,5-13H2,1-4H3/t14-,15+,16+,17+,18+,20+,22+,23+/m1/s1
IUPAC Name
(1S,3aS,3bR,5aS,8R,9aS,9bS,11aS)-8,9a,11a-trimethyl-7-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl propanoate
SMILES
[H][C@@]12CC[C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)[C@H](C)C[C@]12C

References

General References
Not Available
KEGG Drug
D01534
ChemSpider
194604
ChEBI
31523
ChEMBL
CHEMBL1201048
ZINC
ZINC000004213057
PharmGKB
PA164760855
Wikipedia
Drostanolone_propionate

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.000631 mg/mLALOGPS
logP4.76ALOGPS
logP5.1ChemAxon
logS-5.8ALOGPS
pKa (Strongest Basic)-6.9ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area43.37 Å2ChemAxon
Rotatable Bond Count3ChemAxon
Refractivity101.96 m3·mol-1ChemAxon
Polarizability43.19 Å3ChemAxon
Number of Rings4ChemAxon
Bioavailability1ChemAxon
Rule of FiveNoChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on September 02, 2018 00:01 / Updated on February 21, 2021 18:54